Komagatella phaffi (Pichia pastoris)
| Protein name |
Ovomucoid |
| Host compatibility |
Komagatella phaffi (Pichia pastoris) |
| Yield |
3.2 g/L (Beck et al., 2025)
|
| Scale (in specific example) |
Industrial scale |
| Biggest scale product has been develloped in this organism |
Industrial scale (The EVERY Company) |
| Regulatory status in Europe |
Not allowed |
| Regulatory status in other parts of the world |
FDA GRAS approval in the US. Not allowed in Canada
|
| Companies producing this protein in this organism |
The EVERY Company
|
| Extra/remark |
|
| Publications/references |
-
Beck, F., Noll, P., Schweiggert-Weisz, U., & Henkel, M. (2025). Scientific and technological challenges of recombinant egg protein production. BMC Biotechnology. https://doi.org/10.1186/s12896-025-01002-3
-
The EVERY Company. (2025). Our Solutions | EVERY. The Every Company. Retrieved September 2, 2025, from https://every.com/our-solutions/#ovoboost
-
Abeyrathne, E., Lee, H., & Ahn, D. (2013). Egg white proteins and their potential use in food processing or as nutraceutical and pharmaceutical agents—A review. Poultry Science, 92(12), 3292–3299. https://doi.org/10.3382/ps.2013-03391
-
Rekom Biotech S.L. (n.d.). Recombinant allergen Gal d 1. Retrieved September 2, 2025, from https://www.rekombiotech.com/en/recombinant-allergens/gal-d-1
|